Drug Similarity Search Based on Combined Signatures in Gene Expression Profiles

Abstract

ObjectivesRecently, comparison of drug responses on gene expression has been a major approach to identifying the functional similarity of drugs. Previous studies have mostly focused on a single feature, the expression differences of individual genes. We provide a more robust and accurate method to compare the functional similarity of drugs by diversifying the features of comparison in gene expression and considering the sample dependent variations.MethodsFor differentially expressed gene measurement, we modified the conventional t-test to normalize variations in diverse experimental conditions of individual samples. To extract significant differentially co-expressed gene modules, we searched maximal cliques among the co-expressed gene network. Finally, we calculated a combined similarity score by averaging the two scaled scores from the above two measurements.ResultsThis method shows significant performance improvement in comparison to other approaches in the test with Connectivity Map data. In the test to find the drugs based on their own expression profiles with leave-one-out cross validation, the proposed method showed an area under the curve (AUC) score of 0.99, which is much higher than scores obtained with previous methods, ranging from 0.71 to 0.93. In the drug networks, we could find well clustered drugs having the same target proteins and novel relations among drugs implying the possibility of drug repurposing.ConclusionsInclusion of the features of a co-expressed module provides more implications to infer drug action. We propose that this method be used to find collaborative cellular mechanisms associated with drug action and to simply identify drugs having similar responses.

Quantitative Identification of Compound‐Dependent On‐Modules and Differential Allosteric Modules From Homologous Ischemic Networks

“…Modules are considered to be stable groups in biological networks, and the module biomarkers may be robust, which are not likely to be affected by individual gene expression changes . Thus, a coexpressed module may provide more implications to infer drug actions . The CAMs and UAMs of different drugs may serve as universal or specific targets in disease treatment.…”

Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes

“…Similarity matrices constructed on these gene expression profiles can be exploited to cluster drugs to categorize potential mechanisms of action and generate drug combination hypotheses based on the joint dissimilarity of gene expression patterns of drug pairs as compared to those associated with disease states. 12–15…”

Entropy-based divergent and convergent modular pattern reveals additive and synergistic anticerebral ischemia mechanisms

“…42 In this paper, we developed a novel method to identify drug RMs and elucidated the potential pharmacological mechanisms of different compounds individually (BA, JA or UA) and in combinations (BJ or JU) in treating cerebral ischemia-reperfusion injury. In contrast to conventional studies on drug response that mainly focused on genes and pathways, [43][44][45] our method focused on modules and analyzed both their topological structures and functions, which provided a holistic view of the overall differences and similarities in the pharmacological effects of the five compounds at a systems level. All of the compounds contained more RM D s than RM E s, indicating that several modules vanished after drug intervention.…”